Search clinical trials for: machine-learning algorithm

Total 10000 results

Vanderbilt University
National Institutes of Health (NIH)

Completed

Renin Angiotensin Aldosterone System (RAAS) and Fibrinolysis in Humans: ACEi and PE5i

Metabolic Syndrome
Johnson & Johnson Pharmaceutical Research & Development...
Bayer

Completed

An Efficacy and Safety Study of Rivaroxaban With Warfarin for the Prevention of Stroke and Non-Central Nervous System Systemic Embolism in Patients With Non-Valvular Atrial Fibrillation

Stroke | Embolism | Atrial Fibrillation

United States, Australia, France, Poland, Ukraine, United Kingdom, China, Belgium, Germany, Taiwan, Spain, Argentina, Colombia, Israel, Mexico, Bulgaria, India, Malaysia, Romania, Russian Federation, South Africa, Turkey, Korea, Republic... and more
Sinovac Biotech Co., Ltd

Recruiting

Phase IV Clinical Study of sIPV Administration in Adolescent and Adult Populations

Poliomyelitis

China
SF Research Institute, Inc.
Sabinsa Corporation

Recruiting

Effects of Sabroxy® Supplementation on Insulin Resistance and Cognitive Function in Adults With Mild Cognitive Impairment and Insulin Resistance

Insulin Resistance | Mild Cognitive Impairment | Cognitive Decline | Neurodegenerative Disorders

United States
Eveliqure Biotechnologies GmbH

Recruiting

Safety, and Efficacy Study of ShigETEC, a Live, Attenuated, Oral Combination Vaccine to Prevent Shigella and ETEC Disease Delivered to Healthy Adults Ages 18 to 50 Years Old

Shigella

United States
University of Witwatersrand, South Africa
Bill and Melinda Gates Foundation; World Health Organization

Recruiting

A Clinical Trial on Safety in Pregnant Women and How Well the Infant is Protected Against RSV-associated Lower Respiratory Tract Infection When the Pregnant Woman Receives the Approved RSV Vaccine Compared to a Placebo.

Preterm Labour | RSV Immunisation | RSV Infections

South Africa, Ghana, Kenya, The Gambia
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.
Hunan Provincial Center for Disease Control and Prevention

Not yet recruiting

Omicron BA.4/5-Delta COVID-19 Vaccine Phase I Clinical Trial

COVID-19
Shanghai Cell Therapy Group Co.,Ltd

Recruiting

Exploratory Study on Baize DC Injection in Preventing Recurrence and Metastasis After Radical Tumor Surgery

Solid Tumor

China
Sidney Kimmel Comprehensive Cancer Center at Johns...
Oncovir, Inc.

Recruiting

Peptide Vaccine To Prevent Acquired Resistance In Patients With Advanced ALK+ NSCLC (ARCHER)

NSCLC Stage IV | ALK Fusion Protein Expression

United States
Aristotle University Of Thessaloniki
1st ORL Department, AHEPA Hospital, Aristotle University of Thessaloniki; Department... and other collaborators

Recruiting

Biomarkers of Response to Mepolizumab Treatment in Patients With Nasal Polyps With or Without Bronchial Asthma (CALIOPI)

Asthma | Chronic Rhinosinusitis With Nasal Polyps

Greece
Washington University School of Medicine
Eli Lilly and Company; National Institute on Aging (NIA); Alzheimer's Association

Recruiting

A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation (DIAN-TU)

Dementia | Alzheimers Disease | Alzheimers Disease, Familial

United States, Canada, Argentina, Australia, Colombia, Italy, Puerto Rico, United Kingdom, France, Netherlands, Spain, New Zealand, Germany, Mexico
Beth Israel Deaconess Medical Center
Rambam Health Care Campus; Dana-Farber Cancer Institute; United States Department... and other collaborators

Completed

Blockade of PD-1 in Conjunction With the Dendritic Cell/Myeloma Vaccines Following Stem Cell Transplantation

Multiple Myeloma

United States, Israel
Sanofi Pasteur, a Sanofi Company

Completed

Study With Quadrivalent Recombinant Influenza Vaccine (RIV4) in Participants 9 Through 49 Years of Age.

Influenza Immunization

United States, Poland, Spain, Czechia
Morehouse School of Medicine

Completed

RADx-UP- Impact of Community Health Worker Deployment

COVID-19 | Diabetes | Health Behavior | Health Knowledge, Attitudes, Practice | Community Health Workers

United States
University of Oxford
European and Developing Countries Clinical Trials Partnership (EDCTP); Institut...

Completed

Safety, Immunogenicity and Efficacy of R21 Matrix-M in 5-17 Month Old Children in Nanoro, Burkina Faso

Malaria,Falciparum

Burkina Faso
University of Alabama at Birmingham

Withdrawn

Exercise and Posture in Individuals with Osteoporosis (EXPO)

Osteoporosis
VA Eastern Colorado Health Care System

Active, not recruiting

Impact of HIV-1 and Aging on Mucosal Vaccine Responses

HIV Infections | HIV/AIDS | Human Immunodeficiency Virus | HIV-1-infection

United States
Meiji Seika Pharma Co., Ltd.

Completed

Efficacy and Safety Study of ME1111 in Patients With Onychomycosis

Onychomycosis

United States
CanSino Biologics Inc.
Beijing Institute of Biotechnology

Withdrawn

Study to Evaluate the inHaled Recombinant COVID-19 Vaccine (Adenovirus Type 5 Vector) On the Protective-Efficacy in Adults (SeiHOPE)

COVID-19
Jiangsu Rec-Biotechnology Co., Ltd.
IQVIA Pty Ltd

Completed

Safety, Reactogenicity and Immunogenicity Study of ReCOV

Covid19

New Zealand
Wits Health Consortium (Pty) Ltd
Fred Hutchinson Cancer Center; Janssen Vaccines & Prevention B.V.; National Institute... and other collaborators

Completed

Sisonke (Together): OPEN LABEL TRIAL COVID-19 (Sisonke)

SARS (Severe Acute Respiratory Syndrome)

South Africa
Queen Mary University of London

Completed

Influence of Dietary Nitrate on Vascular Dysfunction and Inflammation

Cardiovascular Diseases

United Kingdom
Sohag University

Completed

Value of Cortactin Expression in Invasive and Non-invasive Urinary Bladder Urothelial Carcinoma in Egyptian Population

Urothelial Carcinoma

Egypt
Baxalta now part of Shire
Baxter Innovations GmbH

Completed

Phase 1/2 Lyme Vaccine Study

Prophylaxis of Lyme Borreliosis

Germany, Austria
Public Health England
Institute of Child Health; St George's, University of London

Completed

A Trial Comparing Two Pertussis-containing Vaccines in Pregnancy and Vaccine Responses in UK Mothers and Their Infants (iMAP2)

Responses to Infant Immunisations

United Kingdom
Jonsson Comprehensive Cancer Center

Completed

Vaccine Therapy in Treating Patients With Advanced Kidney Cancer

Kidney Cancer

United States
Seqirus

Completed

Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of an MF59-Adjuvanted Quadrivalent Influenza Vaccine Compared to Non-influenza Vaccine Comparator in Adults ≥ 65 Years of Age

Influenza

Turkey, Philippines, Thailand, Malaysia, Lithuania, Colombia, Czechia, Estonia, Bulgaria, Latvia, Poland, Romania
Immunitor LLC

Unknown

Open Label Immunotherapy Trial of Inoperable Pancreatic Cancer (V3-P)

Pancreatic Cancer Non-resectable

Mongolia
Statens Serum Institut
Quintiles, Inc.; Bill and Melinda Gates Foundation; Larix A/S

Completed

3 Adjuvated Reduced Dose IPV-Al SSI and Non-adjuvated Full Dose IPV SSI Given as Primary Vaccinations to Infants

Poliomyelitis

Dominican Republic
GlaxoSmithKline

Completed

Challenge Dose of Hepatitis B Vaccine in Subjects Who Previously Received Engerix™-B Vaccine

Hepatitis B

Australia, Belgium
Assistance Publique Hopitaux De Marseille

Unknown

Antibiotic Stewardship in Infectious Disease Departement

Infectious Disease

France
Biota Pharmaceuticals, Inc.

Completed

Phase 1 Safety and Pharmacokinetics Study of Single Ascending Doses of BTA-C585 in Healthy Volunteers

Healthy Volunteers | Pharmacokinetics

United States
Serum Institute of India Pvt. Ltd.
Centers for Disease Control and Prevention; University of Colorado, Boulder

Completed

A Clinical Trial to Assess the Safety of a Measles Vaccine (Dry Powder) Administered by Two Different Devices (PMV-001)

Prophylaxis for the Measles Infection

India
University Hospital Tuebingen

Completed

Effect of Morning vs. Evening Vaccination on Hypoxia and Bradycardia of Preterm Infants: a Randomised Controled Trial

Premature Birth | Intermittent Hypoxiema

Germany
Helsinki University Central Hospital
Tampere University Hospital

Completed

Immunogenicity of 13-valent Pneumococcal Conjugate Vaccine Compared to the Pneumococcal Polysaccharide Vaccine in Adult Kidney and Liver Transplant Patients (SOT13)

Liver Transplantation | Kidney Transplantation

Finland
Genexine, Inc.

Completed

Dose-finding, Safety Study of Plasmid DNA Therapeutic Vaccine to Treat Cervical Intraepithelial Neoplasia

Cervical Intraepithelial Neoplasia

Korea, Republic of
Merck Sharp & Dohme LLC

Completed

V501 Efficacy Study in Women Aged 18 to 26 (V501-027)

HPV Infections
Novartis Vaccines

Completed

Single-blind, Dose-ranging Study of Novel Swine Influenza Virus Vaccine in Japanese Adult Subjects

Influenza

Japan
Imperial College London
European Commission

Completed

The Safety and Immunogenicity of the DNA-GTU Vaccine Administered to HIV-infected Patients on ART vs Placebo (CUTHIVTHER001)

HIV

United Kingdom
European Organisation for Research and Treatment...
Centre Hospitalier Universitaire Vaudois; Inovio Pharmaceuticals

Withdrawn

A Phase II Clinical Trial of Chemo-radiotherapy in Combination With INO-3112 in Patients With Locally Advanced Cervical Cancer

Uterine Cervical Neoplasms

Switzerland
Sanaria Inc.
Swiss Tropical & Public Health Institute; Ifakara Health Institute; Tanzania...

Completed

Dose Escalation, Randomized Controlled Trial to Evaluate the Safety, Immunogenicity and Efficacy of Intravenously Administered Attenuated Plasmodium Falciparum Sporozoite Vaccine (PfSPZ Vaccine) in Tanzanian Adults

Malaria | Plasmodium Falciparum Malaria

Tanzania
Sanofi Pasteur, a Sanofi Company

Completed

Study to Determine a Preference for Fluzone Vaccine Given Intradermally (ID) and Intramuscularly (IM) in Healthy Adults

Influenza

United States
Karolinska University Hospital

Completed

Pneumococcal Vaccine in Untreated CLL Patients

Chronic Lymphocytic Leukemia

Sweden
Ology Bioservices

Completed

Safety and Immunogenicity Study of a Booster Vaccination With a Non-Adjuvanted H5N1 Influenza Vaccine (Follow Up to Study 810501)

Influenza

Austria
Sanofi Pasteur, a Sanofi Company

Completed

Immunogenicity and Safety of a Vaccine Against Influenza (2010-2011 Northern Hemisphere Season, Intradermal Route)

Influenza

Belgium
National Institute of Allergy and Infectious Diseases...

Completed

Sanofi H1N1 Influenza Vaccine Administered at Different Dose Levels With and Without AS03 Adjuvant in Healthy Adult and Elderly Populations

Influenza

United States
Sanaria Inc.
The PATH Malaria Vaccine Initiative (MVI)

Completed

Clinical Trial of the PfSPZ Vaccine

Plasmodium Falciparum

United States
Sanofi Pasteur, a Sanofi Company

Completed

Lot-to-Lot Consistency Study of the Investigational, Inactivated, Split-Virion Influenza Vaccine in Adults

Influenza | Orthomyxoviridae Infection | Myxovirus Infection

Spain, France, Lithuania, United Kingdom
University of Washington
GlaxoSmithKline; Asociación Civil Impacta Salud y Educación, Peru

Completed

HSV-2 Suppression to Reduce HIV-1 Levels in HIV-1 Co-infected Persons

HIV Infections | Sexually Transmitted Diseases | Herpes Simplex

Peru
National Cancer Institute (NCI)

Completed

Vaccine Therapy in Treating Patients With Stage IV Melanoma

Melanoma (Skin)

United States

Search clinical trials for: machine-learning algorithm

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Argentina

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations